SVETLANA SHIMBERG: Open Payments
NPI 1982151080 · CHELMSFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 12 payments from 6 companies in 2025. Trend: 2023 $1,557 · 2024 $996 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $76 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| Novo Nordisk Inc | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Viatris Specialty LLC | 1 | $24 |
Products named: REXULTI, FARXIGA, CREON, VRAYLAR, Ozempic, JARDIANCE, YUPELRI.
Industry payments across MA — which companies pay providers there.
